We Still Can't Ignore Long Covid... Dr. Jeffrey Cleland, CEO Ashvattha Therapeutics

episode

BioTech Nation ... with Dr. Moira Gunn not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Full Show — September 22, 2026 2h 46m · 22 Sep 2026 · Rahimi & Grote Show

PDB Afternoon Bulletin | September 22nd, 2026: Tehran Offers To Reopen Hormuz & North Korea’s New Weapon 15 min · 22 Sep 2026 · The President's Daily Brief

US hits out at Aus opt-out laws + The Houthis vs Saudi Arabia explained 28 min · 22 Sep 2026 · The Briefing

Bears quarterback Tyson Bagent lands in concussion protocol (Hour 4) 40 min · 22 Sep 2026 · Rahimi & Grote Show

TAFS Unplugged: Iceage 14 min · 22 Sep 2026 · The Adam Friedland Show

'Lanterns' Episode 6 Deep Dive | House of R 1h 41m · 22 Sep 2026 · House of R

Report any issue

Source

Recorded02 Aug 2023

Publisherfeeds.transistor.fm ↗

Handlerec:13349851

Show notes

In this week's episode of Biotech Nation, Dr. Jeffrey Cleland, the President and CEO of Ashvattha Therapeutics, discusses their drug development efforts to address long COVID. They discuss the definition of long COVID by the World Health Organization, the prevalence of the condition, and the chronic inflammation that occurs in the body, including the brain. Dr. Cleland explains how their nanomedicine approach aims to selectively target and turn off reactive inflammatory cells, potentially offering a treatment for long haul COVID and other diseases.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in